Acetamide, 2, 2-dichloro-N-[2-hydroxy-1- (hydroxymethyl)-2-(4-nitrophenyl)ethyl]- , [R-(R*,R*)]- Tega-Cetin Tevcosin
Gemcitabine hydrochloride is a new synthetic difluoronucleoside anti-metabolic anti-tumor drug, developed by Eli Lilly Company, in 1995 in South Africa, Sweden, the Netherlands, Australia and other countries approved for the market, in 1996 the United States Food and Drug Administration (FDA) approved clinical use in the treatment of non-small cell lung cancer and pancreatic cancer first-line treatment. The main manufacturers of gemcitabine hydrochloride in China are Jiangsu Hausen Pharmaceutical Co., LTD., Harbin Yuheng Pharmaceutical Co., LTD.
Gemcitabine hydrochloride is a new synthetic difluoronucleoside anti-metabolic anti-tumor drug, developed by Eli Lilly Company, in 1995 in South Africa, Sweden, the Netherlands, Australia and other countries approved for the market, in 1996 the United States Food and Drug Administration (FDA) approved clinical use in the treatment of non-small cell lung cancer and pancreatic cancer first-line treatment. The main manufacturers of gemcitabine hydrochloride in China are Jiangsu Hausen Pharmaceutical Co., LTD., Harbin Yuheng Pharmaceutical Co., LTD.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View